v3.26.1
Segment Information - Geographic Information (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues from external customers by geographic area    
Total revenues $ 781.5 $ 794.4
Total Tyvaso    
Revenues from external customers by geographic area    
Total revenues 457.5 466.3
Tyvaso DPI    
Revenues from external customers by geographic area    
Total revenues 330.3 302.5
Nebulized Tyvaso    
Revenues from external customers by geographic area    
Total revenues 127.2 163.8
Remodulin    
Revenues from external customers by geographic area    
Total revenues 126.6 138.2
Orenitram    
Revenues from external customers by geographic area    
Total revenues 135.6 120.7
Unituxin    
Revenues from external customers by geographic area    
Total revenues 53.6 58.2
Adcirca    
Revenues from external customers by geographic area    
Total revenues 2.9 6.0
Other    
Revenues from external customers by geographic area    
Total revenues 5.3 5.0
U.S.    
Revenues from external customers by geographic area    
Total revenues 744.2 749.6
U.S. | Total Tyvaso    
Revenues from external customers by geographic area    
Total revenues 442.9 441.1
U.S. | Tyvaso DPI    
Revenues from external customers by geographic area    
Total revenues 330.3 302.5
U.S. | Nebulized Tyvaso    
Revenues from external customers by geographic area    
Total revenues 112.6 138.6
U.S. | Remodulin    
Revenues from external customers by geographic area    
Total revenues 108.8 120.2
U.S. | Orenitram    
Revenues from external customers by geographic area    
Total revenues 135.6 120.7
U.S. | Unituxin    
Revenues from external customers by geographic area    
Total revenues 49.0 56.9
U.S. | Adcirca    
Revenues from external customers by geographic area    
Total revenues 2.9 6.0
U.S. | Other    
Revenues from external customers by geographic area    
Total revenues 5.0 4.7
ROW    
Revenues from external customers by geographic area    
Total revenues 37.3 44.8
ROW | Total Tyvaso    
Revenues from external customers by geographic area    
Total revenues 14.6 25.2
ROW | Tyvaso DPI    
Revenues from external customers by geographic area    
Total revenues 0.0 0.0
ROW | Nebulized Tyvaso    
Revenues from external customers by geographic area    
Total revenues 14.6 25.2
ROW | Remodulin    
Revenues from external customers by geographic area    
Total revenues 17.8 18.0
ROW | Orenitram    
Revenues from external customers by geographic area    
Total revenues 0.0 0.0
ROW | Unituxin    
Revenues from external customers by geographic area    
Total revenues 4.6 1.3
ROW | Adcirca    
Revenues from external customers by geographic area    
Total revenues 0.0 0.0
ROW | Other    
Revenues from external customers by geographic area    
Total revenues $ 0.3 $ 0.3